Usually not. Venture capital funds and most angels won’t sign an NDA before a first meeting, and asking signals that you’re new to fundraising. Protect yourself by controlling what you share instead: explain what your product does and why it wins without revealing how it works, file patent applications before you pitch inventions, and save truly sensitive information for diligence, when confidentiality agreements are normal. The main exception is a strategic investor, such as the venture arm of a company in your market, where an NDA is reasonable and often expected.
Key takeaways
- Professional investors see hundreds of companies a year, many in overlapping markets, so they won’t sign NDAs to hear a pitch.
- In early meetings, share what your product does and why it wins, not how it works. A good pitch doesn’t depend on secrets.
- File at least a provisional patent application before you disclose an invention to anyone outside an NDA.
- In diligence, a short NDA or data room terms are normal, and the term sheet usually adds a binding confidentiality clause.
- Corporate and strategic investors are different. Ask for an NDA that limits how they use your information and keeps it away from their business teams.
Why won’t investors sign an NDA?
A venture fund looks at hundreds or thousands of companies a year, many of them in the same markets, and it already owns stakes in some of your competitors. If it signed an NDA with every founder who pitched, it would be bound by overlapping promises it could never track, and any portfolio company that later built something similar to yours could become a lawsuit. Reviewing and tracking those agreements would also cost real money. So almost every fund has a firm policy of no NDAs for pitches, and many experienced angels follow the same rule for the same reasons.
What protects you instead is reputation. Investors depend on founders trusting them with their plans, and a fund known for passing ideas to its portfolio would stop seeing good deals. That isn’t a legal guarantee, which is why your real protection is deciding what to share.
What should I share at each stage?
What an investor needs to see grows as the conversation gets more serious, and so can what you share.
| Stage | What to share | What to hold back |
| First meeting and deck | The problem, what your product does, why customers choose it, traction, team and the raise | How the technology works in detail, unfiled inventions, customer names you don’t have permission to use |
| Follow-up meetings | Deeper metrics, a product demo, pipeline and the financial plan | Source code, proprietary data, confidential contract terms |
| Diligence, after a term sheet | The data room: contracts, cap table, financials, IP filings, customer references | Anything a customer contract forbids you to disclose, until you have consent |
| Technical diligence | An architecture walkthrough, sometimes a code review by an outside expert | Full source code access, unless it’s truly necessary |
A pitch that only works if you reveal your secrets usually isn’t working. Investors fund evidence that the product works and that customers want it, and you can show both without explaining exactly how you built it. See How Do I Build a Pitch Deck for a Seed Round?
How do I protect my IP before I pitch?
Protect it before the meeting, not with a document at the meeting. If you have an invention that might be patentable, file at least a provisional patent application before you describe it to anyone outside an NDA. In the US, your own public disclosure starts a one-year clock to file, but Europe, China and many other countries give no general grace period, so an early disclosure can cost you patent rights there. See Startup Patents: Are They Worth It?
Trade secrets, such as source code, model weights, training data and pricing models, stay protected only if you take reasonable measures to keep them secret. Handing them to people who haven’t agreed to keep them confidential undercuts that, so keep them out of your deck and your early meetings. See What Are Trade Secrets? and How Do I Protect My Startup Idea?
Also check what you owe others. Many customer contracts forbid you from naming the customer or sharing contract terms. Get permission before you put a customer’s logo in your deck or offer them as a reference.
When is it reasonable to ask for an NDA?
In diligence. Once an investor has signed a term sheet or is seriously evaluating a deal, it will usually agree to confidentiality before reviewing your data room, either through a short NDA or the data room’s access terms. The term sheet itself normally includes a binding confidentiality clause. That clause usually runs both ways: you can’t share the term sheet beyond your advisors and existing investors either.
With strategic and corporate investors. The venture arm of a company in your market isn’t like a financial investor. Its parent may compete with you, buy from you or want to acquire you someday, and its business teams could use what you share. Ask for an NDA before you share anything sensitive, and ask that it limit use of your information to evaluating the investment and keep it within the investment team, away from product and business development groups. Most corporate investors expect this. Think the same way about the information rights you grant after the investment.
For later-stage companies and narrow disclosures. A company with real revenue running a targeted process with a handful of investors can reasonably ask for a short NDA. And if an investor genuinely needs to see one specific piece of highly sensitive information, such as an unfiled invention at the heart of the company, it’s fair to ask for an NDA covering just that.
What does an investor NDA look like?
It’s shorter and more investor-friendly than a commercial NDA. Expect it to limit use of your information to evaluating the investment, last for a fixed period such as one or two years, and allow sharing with the investor’s partners and advisors. Expect it to say that the investor reviews and invests in many companies, including some that may compete with yours, and that nothing in the NDA stops it from doing so as long as it doesn’t use your confidential information. Some investors also ask for a residuals clause, which lets their people use general ideas they remember without the documents in front of them. Push back on that if what you’re sharing is technical. A general-purpose NDA template usually needs adapting for an investor, so have your lawyer review it. See NDA: What It Means for Startups.
What if an investor uses my idea anyway?
It’s rare, and without an NDA your legal options are limited. That’s why the practical protection is controlling what you share and choosing investors carefully. Before you go deep with a fund that has a company in your market, ask founders it has backed how it handles confidential information. See How Do I Find the Right Angel Investors? for how to check out an investor before you take their money.
Go deeper: For what to share and when across a full round, see our Founder’s Guide to SAFEs and Founder’s Guide to Seed Funding.
If you need an NDA for diligence or a strategic investor, see our NDA service or contact us.
